Board Performance · 2025
In this section14 topics
- Prevention of Conflicts of Interest3 items
- Prevention of the Use of Inside Information3 items
- Anti-Corruption4 items
- Whistleblowing3 items
- Selection of Directors & Chief Executives5 items
- Selection of Independent Directors2 items
- Director Development1 item
- Evaluation of Board & Subcommittee Performance3 items
- Subcommittees1 item
- Meeting Attendance & Remuneration3 items
- Supervision of Subsidiaries & Associated Companies4 items
- Board Duty Performance — Overview1 item
- Audit Committee Duty Performance1 item
- Executive Committee Duty Performance1 item
Prevention of Conflicts of Interest
Has the Company Acted to Prevent Conflicts of Interest?
Yes
Operations in the Past Year
The Company places great importance on good corporate governance, recognizing that conducting business under transparent, fairness, and accountable governance principles is a key factor in building confidence among shareholders, investors, and all stakeholders. The Company has therefore established relevant policies and practices under its Corporate Governance Policy, including the Code of Conduct and Business Ethics, to serve as guiding frameworks for the performance of duties by directors, executives, and employees at all levels. These frameworks set the standards for conducting business with integrity, responsibility, and due regard for the best interests of the organization and its stakeholders.
In addition, the Company places importance on continuously communicating and fostering understanding of such policies and practices, carried out through training programs, dissemination of information via internal communication channels, and the promotion of an organizational culture grounded in ethical principles. These efforts aim to ensure that employees at all levels are aware of, understand, and are able to properly implement the policies and practices in their work, thereby contributing to the establishment of a transparent and efficient working system and reinforcing confidence among all stakeholders.
With regard to the prevention of conflicts of interest, the Company has established clear policies and practices to prevent and manage situations that may give rise to conflicts of interest. Such policies are implemented based on the principles of transparency, fairness, and integrity under sound business ethics, to ensure that business decisions are made rationally, independently, and with due consideration of the Company’s best interests as the foremost priority.
The Company requires directors, executives, employees, as well as persons who may have conflicts of interest and/or related persons, to fully and transparently disclose information regarding their interests and those of their related parties to the Company. In addition, such persons must refrain from participating in the consideration, approval, or decision-making process for any transaction in which they have an interest. This measure aims to prevent any misuse of authority or actions that may adversely affect the interests of the Company and its shareholders as a whole.
Furthermore, the Company has established policies and criteria governing connected transactions and transactions that may involve conflicts of interest in compliance with applicable laws and regulations, including the requirements of the Securities and Exchange Commission and the Stock Exchange of Thailand. The Company has put in place procedures for the careful, transparent, and verifiable consideration and approval of such transactions. The details of connected transactions are also fully disclosed in the Annual Report and other relevant documents to ensure that shareholders and stakeholders are adequately informed in a transparent manner.
Number of Conflict-of-Interest Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to conflicts of interest (cases) | 0 | 0 | 0 |
Prevention of the Use of Inside Information
Has the Company Acted to Prevent the Use of Inside Information?
Yes
Operations in the Past Year
The Company places great importance on maintaining the confidentiality of internal information and preventing the misuse of insider information for personal gain or for the benefit of others. Clear guidelines have therefore been established under the Company’s Code of Conduct and Business Ethics to ensure that directors, executives, and employees at all levels strictly adhere to such principles in the performance of their duties. The Company recognizes that the proper and transparent management of internal information is an essential factor in building confidence among shareholders, investors, and stakeholders, as well as in enhancing the Company’s standards of good corporate governance.
Under these guidelines, the Company requires personnel not to disclose any undisclosed material information to external parties and strictly prohibits the use of such insider information for personal benefit or for the benefit of others, whether directly or indirectly for example the use of insider information for trading in the Company’s securities during periods when the Company is about to announce its operating results, or the use of the Company’s strategic information for personal investment purposes.
In addition, the Company has established systematic measures and supervisory guidelines for executives and related persons to ensure compliance with applicable laws and regulations. The Company also provides education and awareness programs for directors and executives of various functions regarding their duties and responsibilities in reporting their securities holdings, including those of their spouses and minor children. Such programs also cover the legal penalties stipulated under the Securities and Exchange Act B.E. 2535 (1992), as well as the requirements of the Stock Exchange of Thailand, to ensure accurate and complete compliance with all relevant laws and regulations.
The Company requires directors and executives to report their holdings and any changes in the holdings of the Company’s securities to the Securities and Exchange Commission in accordance with the prescribed rules. A copy of such report must also be submitted to the Company on the same day that the report is filed with the Securities and Exchange Commission, so that the Company can appropriately monitor and ensure compliance with the relevant requirements.
Furthermore, the Company has implemented a Securities Trading Policy for directors, executives, and employees to clearly define the guidelines for trading in the Company’s securities. This includes the establishment of blackout periods prior to the disclosure of significant information, in order to prevent the use of insider information for securities trading and to promote transparency and fairness in the Company’s operations for all shareholders and investors.
Number of Inside-Information Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to the use of inside information to seek benefits (cases) | 0 | 0 | 0 |
Anti-Corruption
Has the Company Acted on Anti-Corruption?
Yes
Operations in the Past Year
The Company places great importance on conducting its business under the principles of good corporate governance, transparency, and accountability toward all stakeholders. The Company firmly believes that strong corporate governance and systematic anti-corruption measures are fundamental foundations for building trust and achieving sustainable long-term growth.
The Company has been granted membership certification from the Thai Private Sector Collective Action Against Corruption (CAC), representing the second renewal of such certification. The certification is valid from 31 March 2024 to 31 March 2027. Receiving the CAC certification on this occasion reflects PRINC’s commitment to conducting business with transparency, adhering to good governance principles, and maintaining concrete and effective management systems to prevent corruption risks. The Company has therefore established the following policies:
All directors, executives, and employees of the Company, as well as individuals affiliated with the Company, are prohibited from engaging in, condoning, or supporting any form of fraud or corruption, whether direct or indirect, involving any related individuals or entities. This includes offering, promising, soliciting, demanding, giving or accepting bribes, or engaging in any behavior that suggests fraudulent or corrupt practices. The Company encourages all related organizations, customers, business partners, contractors, and subcontractors to adopt similar practices, as well as government officials. The Company also mandates regular reviews of its practices to ensure compliance with policies, procedures, regulations, rules, announcements, laws, and business changes.
The Company maintains a politically neutral stance and does not participate in any activities that could imply its involvement or support for any political party or faction. The Company remains impartial and does not align itself with any political party or group. Company assets are not to be used to support any political party or candidate. The Company recognizes and respects the rights of its employees to exercise their civic duties as stipulated by the Constitution and other relevant laws.
The Company has a strict policy prohibiting all forms of bribery in its business operations. All business dealings and interactions with both public and private sectors must be conducted transparently, honestly, and in accordance with all applicable laws.
The Company will control charitable donations, sponsorships, business gifts, and support for various activities to ensure transparency and legal compliance.
The Company implements appropriate and regular internal controls and audits to prevent all employees, including third parties associated with the Company, from acting contrary to this policy.
In addition, the Company places importance on communicating and raising awareness of such policies and practices among all stakeholders, including employees, business partners, and suppliers, in order to ensure proper understanding and encourage consistent and continuous compliance. This approach helps foster an organizational culture grounded in integrity, transparency, and social responsibility.
Anti-Corruption Measures
Anti-corruption measures can help the Company mitigate risks that may lead to fraud and corruption within the organization. Therefore, designing and implementing appropriate internal controls, as well as fostering awareness and values against fraud and corruption among the Company's personnel, are crucial factors in preventing organizational fraud and corruption. Anti-corruption measures are secured through five key activities:
1. Corruption Risk Assessment
The purpose of corruption risk assessment is to enable all departments within the Company to proactively identify, assess, and review organizational corruption risks. It also aims to raise awareness of potential risks and their impact on organizational operations, ensuring that corruption risks are addressed promptly. The risk assessment involves four steps:
Step 1: Define risk measurement criteria for impact and likelihood, and establish the organization's acceptable risk levels.
Step 2: Identify corruption risks, their root causes, and impacts, and analyze the severity and likelihood of risks before considering existing internal controls.
Step 3: Evaluate existing internal control systems and analyze the severity and likelihood of risks after considering current internal controls.
Step 4: Implement measures to reduce risks to acceptable organizational levels if existing internal controls are insufficient to prevent corruption risks.
2. Establishment of Policies Related to Anti-Corruption
The Company has implemented policies, operational manuals, and measures aimed at combating fraud and corruption. These include a fraud and corruption risk management manual, good corporate governance guidelines, business ethics principles, practices for political contributions, guidelines for charitable donations and financial support, as well as protocols for giving and receiving gifts, and hosting hospitality events. The purpose is to ensure that employees understand the Company’s ethical principles and adhere to good working practices. Additionally, this aims to foster awareness and instill values of anti-corruption among the Company’s personnel. These policies must be approved by the Company’s Board of Directors. Furthermore, the Company is required to review and update relevant policies and manuals regularly, at least once every two years, to ensure effective management of fraud and corruption risks. This also ensures that operational and legal changes are appropriately reflected in the policies.
3. Communication and Training
Communication and training are essential components of anti-corruption measures. They aim to foster knowledge, understanding, and awareness of the importance of adhering to anti-corruption policies and related manuals, as well as various anti-corruption measures. These efforts encourage participation in the company’s risk management processes while empowering employees to play a role in preventing and detecting fraud and corruption within the organization. Communication with business stakeholders also serves to demonstrate the company’s commitment to anti-corruption principles and transparency in its operations. The Human Resources Department is responsible for creating an annual written communication plan for anti-corruption policies and measures, directed at company employees and business stakeholders. Communication channels include notice boards, training sessions (provided to HR personnel and interested parties within the subsidiaries), announcements via the Company’s intranet system, and updates on the company’s website. Additionally, the company recognizes employees who display integrity, such as those who recover and return lost items to service users. These communication plans and channels are reviewed and approved by the Managing Director annually. To ensure communication effectiveness, the designated plans and communication channels undergo periodic review and evaluation of internal control systems by the Internal Audit Department.
4. Due Diligence on Personnel and Business Stakeholders
Due diligence on personnel and business stakeholders is a crucial factor in effective fraud prevention. The Company assigns the Human Resources Department to conduct background checks on personnel prior to employment or promotion, and the Procurement Department to conduct due diligence on business stakeholders before entering into contracts or transactions. This due diligence is conducted appropriately, within the bounds of applicable laws, and with the consent of the personnel or business stakeholders, as follows:
Pre-employment background checks on personnel to verify qualifications, suitability, and experience of job applicants.
Background checks on personnel prior to assigning them to critical positions within the Company, such as Board members, senior executives, and personnel in financial departments, to verify qualifications, experience, financial reliability, references, or potential conflicts of interest arising from the new position.
Due diligence on business stakeholders, particularly vendors, contractors, and service providers to the Company, to verify their credibility, financial status, reputation, and qualifications related to their products or services. Furthermore, the Board of Directors, executives, and personnel in designated critical positions, as determined by the Human Resources Department, as well as business stakeholders, must report any potential conflicts of interest to the Chief Executive Officer and the Board of Directors annually and during the year (if any changes occur that may lead to conflicts of interest). The Company prohibits personnel with conflicts of interest from participating in procurement processes and will promptly penalize personnel who fail to report conflicts of interest.
5. Internal Controls and Monitoring
The Company emphasizes internal controls, which are practices established jointly by the Board of Directors, executives, and personnel at all levels of the organization to ensure that specified work methods help the organization achieve its objectives. Executives in each department must design appropriate internal controls for their respective areas of responsibility. All departments must create written work procedures for executive review and approval to ensure transparency, independence, and prevention of fraud and corruption. The Company also monitors results and detects fraudulent activities, errors, and non-compliance with regulations to mitigate risks. The Company encourages the use of technology to detect fraud and corruption. The Internal Audit Department is responsible for auditing and reviewing operations annually to ensure compliance with practices and regulatory requirements, and to confirm that the Company has adequate and appropriate internal control systems to address potential corruption risks, and reports to the Audit Committee.
Form of Anti-Corruption Operations
| Operation |
|---|
| The participation in anti-corruption projects |
| Assessment and identification of corruption risk |
| Communication and training for employees on anti-corruption policy and guidelines |
| Review of the completeness and adequacy of the process by the Audit Committee or auditor |
Number of Corruption Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues related to corruption (cases) | 0 | 0 | 0 |
Whistleblowing
Has the Company Implemented Whistleblowing Procedures?
Yes
Operations in the Past Year
The Company places great importance on promoting an organizational culture grounded in transparency, integrity, and social responsibility. The Company recognizes that an effective complaint handling and whistleblowing system is an important mechanism for preventing and detecting fraud or misconduct. The Company has therefore established a Whistleblowing Policy to provide an appropriate channel through which employees as well as external parties may report information or submit complaints regarding any actions that may constitute fraud, corruption, or violations of applicable laws, regulations, and business ethics in a convenient and secure manner.
The Company has established whistleblowing channels that are reliable, independent, and easily accessible. Whistleblowers may choose to disclose their identity or remain anonymous. This approach aims to assure whistleblowers that the information provided will be carefully and fairly considered, while also reducing concerns regarding potential consequences arising from such disclosure. In addition, the Company has implemented appropriate measures to protect whistleblowers and individuals who cooperate in providing information, in order to prevent them from being subject to retaliation, intimidation, harassment, or any adverse consequences as a result of their disclosure. The identity and information of whistleblowers will be kept strictly confidential, and all reported matters will be investigated with fairness and impartiality.
The Company requires personnel to report or disclose information through the established channels whenever they encounter or have knowledge of any actions that may constitute fraud or corruption. The Company will not impose any penalties or take any actions that may negatively affect whistleblowers who report such matters in good faith, even if subsequent investigations determine that the reported information is unfounded. However, in cases where information or allegations are intentionally reported with the intent to cause harm to others, or where false information is provided in bad faith, the Company will take appropriate disciplinary actions against the responsible parties in accordance with the Company’s regulations.
Currently, the Company has established several complaint channels through which external parties may submit complaints or suggestions as follows:
1. Postal Mail : Addressed to the designated recipient at the following address:
Company Secretary
Principal Capital Public Company Limited
23rd Floor, Bangkok Business Center, 29 Sukhumvit 63 Road
Khlong Tan Nuea, Watthana, Bangkok, 10110
2. Website : www.principalcapital.co.th
3. Email : princ_secretarywhistle@princgroup.com
4. Telephone : +66 (2) 009-2015
Additionally, employees who wish to report concerns or submit complaints can contact
Internal Whistleblowing Committee : princ_internalwhistle@princgroup.com or
Company Secretary : princ_secretarywhistle@princgroup.com
The conditions and procedures for considering reports and complaints are detailed in the "Corporate Governance Policy" and on the Company's website, which are accessible to both Company personnel and external parties.
Number of Whistleblowing Cases
| Metric | Current Year | Previous Year | Two Years Ago |
|---|---|---|---|
| Total number of cases or issues received through whistleblowing channels (cases) | 0 | 0 | 0 |
Selection of Directors & Chief Executives
Are Directors Selected Through the Nomination Committee?
Yes
Are Chief Executives Selected Through the Nomination Committee?
Yes
Number of Directors from Major Shareholders
2
Rights of Minority Shareholders on Director Appointment
Recognizing the importance of shareholders and good corporate governance promotion, Principal Capital Public Company Limited, (the “Company”), facilitates shareholders in proposing, in advance of the Annual General Shareholders’ Meeting (AGM), the issue, as deemed appropriate, to be considered to include in the agenda of the meeting. Furthermore, the shareholders can nominate person to be a director in advance of the meeting. By this mean, it will ensure that the agenda will be carefully selected and truly beneficial to the company and qualified directors who will be selected to perform their duties effectively to attain the highest benefits for the Company and the stakeholders and also to affirm the conformity to the good corporate governance.
Qualification of Shareholder
The shareholders who wish to propose the director nominee must possess qualifications according to the criteria as follows:
1. Being the shareholder of the company which can be either one shareholder or combined shareholders and holding shares not less than 5% of the total voting rights of the Company on the date that shareholder nominates the director and on the Record date in order to determine the right of the shareholders to attend the AGM of that year. Or
2. Being the shareholder of the company which can be either one shareholder or combined shareholders and holding shares not less than 300,000 shares an having continuously held those shares for at least one year until the date that shareholder nominates the director and on the Record date in order to determine the right of the shareholders to attend the AGM of that year.
Nomination of a Director
The shareholder who possesses qualifications according to Clause 2 of the Criteria may nominate a person for the director by filling in the Form to Nominate Director and affixing the nominee’s signature. The evidence of shareholding, namely, the certified letter of the securities company or other evidence from the Thailand Securities Depository the evidence of nominee’s consent, supporting documents of candidates’ qualifications such as education and work experience, together with supporting document beneficial for board consideration must be delivered to the Company within 31st December each year.
Method of Director Appointment
| Method |
|---|
| Method whereby each director requires approval votes more than half of the votes of attending shareholders with voting rights |
Selection of Independent Directors
Criteria for Selecting Independent Directors
Qualifications of Independent Directors of Principal Capital Public Company Limited. It was in line with the definition of the Capital Market Supervisory Board
1. Holding no more than one percent of the total voting shares.
2. Not being an executive director involved in the management of the business, employee, staff, advisor earning regular monthly salary, controlling person during the period of two preceding years. Relaxation of this requirement is in the case where the person is retired as a government official or as a consultant of a government agency which is a majority shareholder or has controlling interest for less than 2 years.
3. Not being a person who is relate by blood or legal relations with a director or an executive.
4. Not having a business relationship with including not being the significant shareholder or the controlling person of a juristic person having a business relationship with the company in an amount starting from 20 million baht or more or from three percent of NTA, whichever amount is lower, unless such foregoing relationships have ended for at least two years prior to the date of filing.
5. Not being an auditor of the company, its parent company, subsidiary, associate company, a major shareholder, a controlling person, unless such foregoing relationships have ended for at least two years prior to the date of filing.
6. Not being a provider of professional services, a significant shareholder, controlling person, or partner of such provider with a service fee of more than two million baht per year during the period of two preceding year. * In case of a person who has qualifications inconsistent with 4 and 6, he or she shall be granted an exemption from such prohibition, provided that the issuer has obtained an opinion of the board of directors indicating that after a consideration in accordance with the principle in Section 89/7, the appointment of such person does not affect the performance of duties and the giving of independent opinions, and that the following information has also been disclosed in the notice calling the shareholders' meeting.
7. Not being a director who is appointed as the representative of directors of the issuer, major shareholder or shareholder who is a connected person of a majority shareholder.
8. Not undertaking any business of the same nature and in competition with the company and the subsidiary, or holding more than one percent of the voting shares, or being a managing director, employee, staff, advisor with a regular monthly salary, person with controlling interest in such business.
9. Not having any other characteristics that cause the inability to express independent opinions.
10. An independent director can be an independent director of an affiliated company, but a member of the Audit Committee is prohibited from being a director of a parent company, subsidiary or subsidiary at the same level (sister company) which are listed companies.
11. After being appointed as an independent director, that independent director may be assigned by the board of directors to make a decision on the business operation, the parent company, subsidiary, associate company, sister company, major shareholder or controlling person in the form of collective decision. However, a member of the Audit Committee is prohibited from taking part in the decision-making on the business operation.
Did Any Independent Director Have a Business or Professional Relationship?
No
Director Development
Director Development — Introduction
Director and Executive Development
• Understanding of Duties
Upon the appointment of a new director, the Nomination and Remuneration Committee assigns the Company Secretary to deliver the board charter and corporate governance policies to the newly appointed director. The Company Secretary also explains the roles, duties, and responsibilities of the director and coordinates for the director to receive an orientation from the management team. The director also receives documents including information about the Company, the nature of its business, the organizational mission, and business direction.
In addition, the Nomination and Remuneration Committee assigns the Company Secretary to disseminate information about relevant and necessary training courses for directors to ensure they can perform their duties completely, transparently, in accordance with good corporate governance principles, and protect the interests of all stakeholders effectively.
In the case of recruiting new senior management, the Company will provide in-depth, one-on-one orientation to ensure that the new senior executives receive information about the Company, the nature of its business, the organizational mission, and business direction. They will also receive presentations on their scope of work from various key departments to gain an overview of the organization's operations.
• Succession Planning
The Nomination and Remuneration Committee has monitored and directed management to develop and implement a succession plan for senior management positions to ensure business continuity. A succession policy, signed by the Managing Director, has been announced. Progress is reported monthly and the succession plan is reviewed annually. The Committee participates in the recruitment and screening process to ensure that individuals appointed to key positions within the Company possess the appropriate qualifications, experience, skills, and attitudes, and comply with all relevant laws and regulations.
• Director Development
The Company promotes and supports training and education on corporate governance principles for its directors on specific topics to enhance and continuously develop their performance. In addition, all Company directors have completed the Director Certification Program (DCP) from the Thai Institute of Directors Association (IOD), as well as other relevant courses such as
The Role of the Chairman Program (RCP),
Advanced Audit Committee Program (AACP),
Director Accreditation Program 2006 (DAP),
Strategic Board Master Class,
Executive Development Program (EDP), and
Board Nomination and Compensation Program (BNCP)
In addition, the directors have continuously attended seminars and training programs organized by external institutions, including the program Boardroom Excellence: A Key to Corporate Success; the seminar on “ESG under Pressure: How U.S. and EU Policies Shape Thai Business Strategies”; the seminar on “National Director Conference 2025: Stronger Together through the World of Contradiction”; the seminar on “The Strategic Role of an Audit Committee in Cybersecurity Oversight”; and the seminar on “Intensive Lessons from the Capital Market: Staying Ahead of Risks and Empowering Professional Directors.” These participations aim to enhance their knowledge, understanding, and capabilities in corporate governance, thereby enabling them to perform their duties more effectively.
• Executive Development
The Company supports annual development programs for executives and senior management, facilitating access to external training courses such as the seminar on “TLCA CFO Professional Development Program (TLCA CFO CPD) No. 7/2025: Financial Reporting Standards on Sustainability Disclosure (IFRS S1 / IFRS S2)” and the training program “Climate Finance for Professionals.” and organizing internal development programs. These programs aim to enhance executives' knowledge in areas such as good corporate governance, sustainable business practices, and other relevant skills. They also encourage the exchange and expansion of experiences among executives, leading to improved organizational capabilities and operational efficiency.
Evaluation of Board & Subcommittee Performance
Criteria for Evaluating Board Performance
Criteria for Performance Evaluation of the Board of Directors
The performance evaluation of the Board of Directors and the Board Committees is conducted annually. The Nomination and Remuneration Committee (NRC) reviews and determines the criteria and process for evaluating the performance of the Board of Directors, Board Committees, and individual directors on a regular basis to ensure alignment with the principles of good corporate governance.
The topics for the Board performance evaluation (self-assessment) are based on the evaluation form developed by the Thai Institute of Directors (IOD), with key elements covering the following areas:
Board Structure and Qualifications: This covers the appropriateness of the number of directors, their knowledge, experience, independence, and tenure of office.
Board Meetings: Assessment of the appropriateness of meeting schedules, the number of meetings, meeting agendas, the provision of meeting documents in advance, the atmosphere of the meetings, and the recording of minutes.
Roles, Duties, and Responsibilities: Performance of duties in accordance with the charter, transparency in operations, review of the internal control system, and attention to key issues such as risk management, corporate governance, and sustainability.
Board Reporting: For Board Committees, the evaluation includes the regular reporting of activities and progress to the Board of Directors, as well as the preparation of disclosure in the Annual Report.
Individual Director Performance Evaluation, the assessment focuses on capabilities and the performance of duties, with key evaluation topics as follows:
Personal Qualifications: Knowledge, expertise, and ethics.
Readiness to Perform Duties: Understanding of the roles and responsibilities as well as the Company’s business.
Participation and Performance in Meetings: Preparation through reviewing materials prior to meetings, providing constructive opinions, and maintaining proper meeting discipline.
Roles, Duties, and Responsibilities: Monitoring the management’s performance without interfering in day-to-day operations, and commitment to continuous self-development.
Relationship with the Board and Management: Maintaining good relationships to ensure effective collaboration and performance.
Evaluation Process
The Company Secretary distributes the self-assessment forms to each director for completion, covering both the Board as a whole and individual director evaluations through the designated evaluation system, which in the past year was conducted in electronic format.
The Company Secretary compiles and summarizes the evaluation results for each category and presents them to the Nomination and Remuneration Committee.
The Nomination and Remuneration Committee analyzes the evaluation results and summarizes key findings, proposing recommendations for improving the Board’s effectiveness to the Board of Directors, with the objective of maximizing benefits for stakeholders and promoting a culture of good corporate governance.
Evaluation of Board Performance in the Past Year
In 2025, Principal Capital Public Company Limited conducted an evaluation of the performance of the Board of Directors and each sub-committee, using a full score of 4.00 points. The overall average score of the Board of Directors resulted in 3.73 out of 4.00, rated at the “Excellent” level. The categories are ranked by score in descending order as follows: (1) Relationship; (2) Meeting Conduct; (3) Roles, Duties, and Responsibilities; (4) Personal Qualities; and (5) Readiness. The individual evaluation results of the directors showed an average score of 3.81 out of 4.00, also rated at the “Excellent” level, reflecting effectiveness in the performance of duties, regular meeting attendance, provision of constructive recommendations, and the performance of duties with independence and prudence.
In addition, the evaluation results of each sub-committee reflected the effectiveness in carrying out their roles, authorities, and responsibilities as stipulated in their respective charters. The details of the evaluation results of each sub-committee are as follows:
1. Audit Committee
The Audit Committee received an average score of 3.95 out of 4.00, rated at the “Excellent” level. This reflects its effectiveness in overseeing financial reporting, internal control systems, risk management, and compliance with relevant laws and regulations in a prudent, transparent, and independent manner, as well as holding regular meetings and appropriately reporting to the Board of Directors.
2. Corporate Governance Committee
The Corporate Governance Committee received an average score of 3.95 out of 4.00, rated at the “Excellent” level. This reflects its effectiveness in promoting and driving good corporate governance principles, business ethics, and corporate governance practices throughout the organization, including continuous monitoring and review of policies to ensure alignment with regulatory requirements.
3. Sustainability Development Committee
The Sustainability Development Committee received a score of 4.00 out of 4.00. This reflects the full and effective performance of its duties in accordance with its charter and its significant role in determining the organization’s ESG and sustainability direction, as well as monitoring environmental, social, and governance performance in line with international standards and stakeholders’ expectations.
4. Risk Management Committee
The Risk Management Committee received an average score of 3.76 out of 4.00. The score reflects a strong level of performance, with further opportunities for enhancement, and reflects opportunities to further enhance the standards and intensity of its operations. The score indicates the directors’ expectations to continuously elevate the risk management system to higher standards.
5. Nomination and Remuneration Committee
The Nomination and Remuneration Committee received an average score of 3.71 out of 4.00. The score reflects changes in the composition of the committee during the year, with new directors joining and not yet having participated in certain key processes in the previous evaluation cycle. The continued learning and familiarization with roles and responsibilities by the new directors will help enhance performance in the following year and further strengthen the nomination and remuneration processes to ensure appropriateness, transparency, and alignment with the Company’s strategic direction.
Evaluation Results
| Evaluated Body | Group — Carried Out? | Group — Grade / Average Score | Group — Grade / Full Score | Individual (Self-Assessment) — Carried Out? | Individual (Self-Assessment) — Grade / Average Score | Individual (Self-Assessment) — Grade / Full Score | Cross (Assessing Other Directors) — Carried Out? |
|---|---|---|---|---|---|---|---|
| Board Of Director | Y | 3.73 | 4 | Y | 3.81 | 4 | N |
| Audit Committee | Y | 3.95 | 4 | N | N | ||
| Other Subcommittee | Y | 3.95 | 4 | N | N | ||
| Other Subcommittee | Y | 3.76 | 4 | N | N | ||
| Other Subcommittee | Y | 4 | 4 | N | N | ||
| Other Subcommittee | Y | 3.71 | 4 | N | N |
Subcommittees
Subcommittees
| Results of the Subcommittee's Duty Performance |
|---|
In 2025, the Nomination and Remuneration Committee convened a total of five meetings. The Committee monitored and supervised the implementation of its responsibilities in accordance with the duties prescribed in its Charter, and regularly reported its performance and recommendations to the Board of Directors for consideration. The key activities undertaken during 2025 are summarized as follows:
The Nomination and Remuneration Committee performed its duties with prudence, transparency, and fairness, adhering to the principles of good corporate governance and focusing on creating sustainable value for the business for the utmost benefit of the Company and all stakeholders. Mr. Watson Chansajcha Chairman of the Nomination and Remuneration Committee |
In 2025, the Sustainability Development Committee undertook various initiatives in order to fulfill its duties and responsibilities in supporting the Board of Directors in advancing the Company’s sustainability agenda. The Committee ensured that such initiatives were conducted in compliance with applicable laws, regulations, and both domestic and international standards, under the framework of good corporate governance and the Company’s sustainability development principles. The approach emphasizes appropriateness, transparency, and accountability, covering three key dimensions: Environmental, Social, and Economic and Governance aspects, while also fostering confidence and trust among all stakeholder groups. Key activities are summarized as follows:
In this regard, the Sustainability Development Committee remains committed to closely supervising, monitoring, and supporting the management team to ensure that the implementation of strategies and initiatives continues to create long-term value for the Company and its stakeholders in a sustainable manner. Mr.Chanin Khaochan Chairman of the Sustainable Development Committee |
In 2025, the Risk Management Committee of Principal Capital Public Company Limited performed its duties in overseeing, supervising, and monitoring the Company’s enterprise risk management in order to support the Group’s growth strategy, business expansion, and sustainable operations. The Committee ensured that risk management practices were aligned with good corporate governance principles by linking corporate strategy with enterprise risk management through the preparation of a Corporate Risk Profile and the classification of risks into seven categories: strategic risk, legal and regulatory compliance risk, financial risk, operational risk, clinical risk, environmental, social and governance (ESG) risk, and emerging risk. This approach was adopted to ensure that risk management is aligned consistently across the organization. The Committee considered and selected risks with high impact on the organization and identified key enterprise-level risks for close monitoring. Management was assigned to prepare risk management plans and report progress to the Committee. In 2025, the Risk Management Committee attended meetings, held discussions, and exchanged views with management, internal auditors, and external auditors on relevant matters on a total of 4 meetings. Information presented covered the following areas: Financial Aspect: The Risk Management Committee monitored the Company’s cash flow and liquidity management to support investment plans and business expansion. Cash flow information was considered, comprising actual operating results for the first six months and projections for the following six months, in order to assess the financial position and future outlook. Recommendations were provided regarding funding sources and the management of financial obligations. Operational Aspect: The Committee oversaw clinical risks by monitoring quality and patient safety indicators, incident reporting, and the management of cases with potential medical litigation risk. Recommendations were provided to prevent recurrence and to enhance service standards across hospitals within the Group. In addition, the Risk Management Committee monitored risks related to medical human resources, particularly shortages in key specialties, workforce management, and measures to support personnel rotation within the network to mitigate operational impacts and support organizational growth. In the same year, the Committee began integrating sustainability-related risks into the enterprise risk management process, covering human rights risks and climate change risks, in order to prepare for future disclosure requirements and to support strategic decision-making. The Risk Management Committee performed its duties with prudence, independence, and a proactive approach to strengthen the Company’s risk management framework, support stable business growth, and build confidence among shareholders and stakeholders. Mr. Nattawuth Prasertsiripong, (M.D.) |
The Corporate Governance Committee comprises three directors, with more than half being independent directors. The Committee emphasizes the independent performance of its duties to ensure that the Company upholds excellent corporate governance practices, with transparency and fairness toward all stakeholders. In 2025, the Corporate Governance Committee convened a total of two meetings, with the key activities summarized as follows: Review and Improvement of Corporate Governance Policies • Reviewed the Corporate Governance Committee Charter to ensure that the composition and terms of office of committee members comply with the applicable requirements. • Considered revisions to the Human Rights Policy, approving enhancements to provide clearer provisions regarding labor rights and children’s rights, in alignment with international standards and the Company’s business context involving pediatric patients. The revisions also emphasize gender equality and women’s rights. • Reviewed the Corporate Governance Policy (CG Policy) and proposed strengthening its application in relation to the use of Artificial Intelligence (AI) to prevent data leakage, as well as the storage of information on cloud systems. Management was also assigned to review related operational processes to ensure alignment with the policy. • Considered the Securities Trading Policy for directors, executives, and employees, with the aim of establishing appropriate rules and practices to ensure transparency and to prevent the misuse of inside information. Monitoring Compliance with Good Corporate Governance Principles • Monitored the Company’s 2025 CG Rating assessment, in which the Company achieved a total score of 95 points, equivalent to a 5-star (Excellent) rating. Although the rating was accompanied by an asterisk in accordance with the evaluator’s new conditions, the Committee instructed management to provide appropriate clarification and management approaches in the One Report and to report such matters at the Annual General Meeting of Shareholders (AGM) to ensure transparency. • Conducted random reviews and oversight of procurement processes and construction supervision, acknowledging the operational framework based on the four pillars of corporate governance, namely transparency, fairness, accountability, and business ethics. Emphasis was placed on the use of the ERP system to ensure that all processes are traceable and that supplier performance evaluations are conducted on a continuous basis. • Provided recommendations to establish corporate governance standards by developing a Corporate Governance workflow and a Compliance Manual applicable to all business units within the group, to serve as a reference framework and ensure that all operations comply with relevant regulations. • Provided opportunities for minority shareholders to propose agenda items for the shareholders’ meeting and to nominate qualified individuals for consideration for election as directors in advance of the 2026 Annual General Meeting of Shareholders, during the period from 30 October 2025 to 31 December 2025. The Corporate Governance Committee remains committed to promoting strong governance values within the organization and continuously enhancing operational standards to keep pace with evolving technologies and regulatory requirements. The Committee focuses on creating sustainable value for the business while strengthening long-term trust among shareholders and all stakeholders. Mr. Watson Chansajcha Chairman of the Corporate Governance Committee |
Meeting Attendance & Remuneration
Meeting Attendance & Remuneration — Introduction
The Board of Directors has established a policy regarding the minimum quorum required at the time resolutions are passed during board meetings. At least two-thirds of the total number of directors must be present. In cases where the resolution involves only directors without conflicts of interest, at least two-thirds of such directors must also be present. Additionally, a meeting exclusively among non-executive directors, without management participation, shall be held once per year. The Company Secretary is responsible for organizing the meetings and sending invitations to the directors for review at least seven days in advance of the meeting. This ensures that the directors have sufficient time to study, consider, and make informed decisions on various matters, as well as arrange their schedules to attend the meeting.
Types of Remuneration of the Board of Directors
Remuneration of Board of Directors and Sub Committees
1. Monetary remuneration
In 2025, the Company held 9 Board of Directors meetings, 4 Audit Committee meetings, 5 Nomination and Remuneration Committee meetings, 15 Executive Committee meetings, 2 Corporate Governance Committee meetings, 3 Sustainable Development Committee meeting, and 4 Risk Management Committee meetings. The total meeting allowance for the Board of Directors and sub-committees amounted to Baht 1,120,000.00 . Additionally, director bonuses from the 2024 performance, recorded as expenses in 2025, were paid in the amount of Baht 3,759,016.39, along with monthly director fees of Baht 4,500,000.00. The total compensation for directors was Baht 9,379,016.39.
Remark: However, the summary details of the remuneration for each board member in 2025, as shown in the table, do not match the total amount mentioned above because the details of four board members could not be included, namely:
1. Dr. Satit Viddayakorn, the details that could not be included amounting Baht 211,475.41.
2. Mrs. Unakorn Phruithithada, the details that could not be included amounting Baht 141,393.44.
3. Mr. Nattawuth Prasertsiripong, the details that could not be included amounting Baht 146,311.48.
4. Mr. Sillapaporn Srijunpetch, the details that could not be included amounting Baht 94,262.30.
2. Other remuneration
2.1 Medical allowance and annual health check-up The Company’s director and the directors of PRINC’s wholly-owned subsidiaries will obtain a medical allowance of Baht 1,000,000 per person per year at Princ Hospital Suvarnabhumi
2.2 Discount medical fee
- The Company’s directors and the directors of PRINC’s wholly-owned subsidiaries receive a 50% discount for medical expenses exceeding Baht 1,000,000 at Princ Hospital Suvarnabhumi
- Spouse, son/daughter, and parents of the Company’s directors and the directors of PRINC’s wholly-owned subsidiaries receive 30% for medical expenses at Princ Hospital Suvarnabhumi during the period that they are in the director position.
2.3 Insured amount
The insured amount for the responsibility of the director and executive and the compensation to the Company (Director and Officers Liability and Company Reimbursement Policy: D&O) was Baht 500 million.
In 2025, the Company provided additional remuneration in the form of welfare benefits. These covered medical expenses and annual health check-ups for the Company's directors and directors of wholly-owned subsidiaries (100% shareholding by PRINC). The total amount paid to Prince Hospital Suvarnabhumi was Baht 1,225,981.77.
Remuneration or Benefits Payable to the Board
| Metric | Amount (Baht) |
|---|---|
| Remunerations or benefits pending payment to the board of directors over the past year (baht) | 0 |
Supervision of Subsidiaries & Associated Companies
Does the Company Have Subsidiaries or Associated Companies?
Yes
Is There a Mechanism for Overseeing Subsidiaries and Associated Companies?
Yes
Mechanism for Overseeing Management of Subsidiaries
The Board of Directors has established a framework for the governance, policies, and operations of the subsidiaries and affiliates in which the Company has made investments at an appropriate level, in order to safeguard the interests of the company and its shareholders. The key practices are as follows:
1. The Company will appoint representatives to serve as directors, executives, or controlling authorities in its subsidiaries and affiliates in proportion to its shareholding, to ensure effective oversight of operations. Such representatives must receive approval from the Board of Directors' meeting prior to assuming their roles.
2. The Company has clearly defined the scope of authority, duties, and responsibilities for its representatives serving as directors or executives in subsidiaries and affiliates to ensure transparency and enable efficient performance of their roles.
3. The Company will continuously monitor the performance of its subsidiaries and affiliates by requiring periodic operational reporting and evaluating their operational efficiency. This process aims to drive improvements and enhance management efficiency.
4. The Company will implement appropriate risk management and internal control systems to identify, assess, and manage risks that may impact the performance of subsidiaries and affiliates effectively.
Additionally, The Company has mechanisms to oversee the disclosure of financial status and performance, transactions between subsidiaries, affiliates, and related parties, as well as the acquisition or disposal of assets or other significant transactions of subsidiaries and affiliates. These must be conducted accurately and in full compliance with the disclosure criteria adopted by the company, via centralized departments such as the Accounting and Finance Division, to ensure:
1. The use of such information in the preparation of the Company’s financial statements in accordance with standards and timelines specified by the Securities and Exchange Commission.
2. The establishment of an appropriate and robust internal control system in subsidiaries to ensure that all transactions comply with applicable laws and related regulations, and that such transactions can be audited by the group’s internal auditors.
Oversight Mechanisms
| Mechanism |
|---|
| Sending representatives to act as directors, executives or controlling persons in proportion to shareholdings |
| Defining the scope of powers, duties and responsibilities of directors and executives who represent the company in setting important policies |
| Disclosure of financial information and operating results |
| Transactions between the Company and related persons |
| Acquisition or disposal of assets |
| Other important transactions |
| Internal control system of the subsidiary operating the core business is appropriate and sufficient in the subsidiary operating the core business |
Board Duty Performance — Overview
Board Duty Performance — Overall Description
In 2025, the Board of Directors of Principal Capital Public Company Limited performed its duties with responsibility, prudence, and commitment to ensuring that the Company’s operations are conducted in accordance with the principles of good corporate governance, while setting strategic directions to support sustainable business growth, with due consideration given to the best interests of shareholders and all stakeholders.
Throughout the year, the Board of Directors convened regularly, holding a total of 9 meetings in 2025 to deliberate on key matters relating to strategy, management, corporate governance, risk management, and the advancement of the Company’s sustainability agenda. The Board also continuously monitored the Company’s performance and provided policy recommendations to the management team to enhance operational efficiency.
Corporate Governance and Organizational Development
The Board of Directors places great importance on strengthening the Company’s corporate governance framework to ensure transparency, efficiency, and alignment with international standards. The Board has established and acknowledged the annual performance evaluation process for the Board of Directors and its subcommittees, based on the guidelines of the Thai Institute of Directors, with the objective of enhancing the effectiveness of the Board in performing its duties.
In addition, the Board has reviewed and revised key policies and charters of the Company. These include the review of the Corporate Governance Committee Charter, with the introduction of guidelines for overseeing the use of artificial intelligence (AI), cloud-based data storage, and data management practices in order to mitigate data-related risks and strengthen the Company’s information technology governance framework. The Board also approved revisions to the Human Rights Policy to provide greater clarity on labor rights, children’s rights, gender equality, and women’s rights. Furthermore, the Board approved and announced the Securities Trading Policy for directors, executives, and employees, establishing appropriate rules and practices to promote transparency and prevent the misuse of inside information.
Strategic Direction and Investment Expansion
The Board of Directors has overseen and approved significant investment projects to support the continued growth of the Group’s businesses. Key initiatives include the expansion of the hospital business through the transfer of Thanakarn Hospital’s operations into the Group’s hospital network, as well as the investment in Por Phat 1 and Por Phat 2 hospitals to strengthen the Group’s healthcare platform.
In addition, the Board has emphasized the application of technology in business operations. The Board assigned management to develop plans relating to Health Tech, digital transformation (Digitalization), and the utilization of healthcare marketing intelligence to enhance the Company’s long-term competitiveness. The Board also encouraged the creation of synergies among hospitals within the network in order to improve operational efficiency across the Group.
Driving Sustainability Across the Organization
The Board of Directors has continuously overseen the Company’s sustainability initiatives. In particular, the Board has focused on strengthening the governance structure for sustainability by considering the appointment of the Chief Executive Officer and the executive responsible for Shared Services operations to serve as members of the Sustainability Development Committee. This initiative aims to enhance the effectiveness of sustainability implementation and to ensure that sustainability objectives are integrated into the Company’s operational practices.
Financial Oversight and Internal Control System
The Board of Directors has supervised the preparation and presentation of the consolidated financial statements and the separate financial statements of the Company on a quarterly basis, which have been reviewed by the certified public auditor. This process is intended to ensure that the Company’s financial information is accurate, transparent, and in compliance with the relevant financial reporting standards.
The Board has also reviewed the Company’s transfer pricing policy among affiliated companies to ensure that such transactions are conducted in accordance with market mechanisms and relevant regulatory requirements. In addition, the Board continuously monitors and evaluates the adequacy of the Company’s internal control system in accordance with the COSO.
Enterprise Risk Management Oversight
The Board of Directors has overseen the Company’s enterprise risk management through the development of the Corporate Risk Profile. The Board has considered key risk issues facing the organization and regularly monitored the Company’s cash flow management and liquidity position in order to support the Company’s investment plans and business expansion.
Regarding the Company’s future direction, the Board of Directors placed importance on adapting to the rapidly changing business environment by assigning the management to review business targets to ensure their appropriateness in light of the current situation.
During the past year, the Board of Directors performed its duties with a strong commitment to good corporate governance by setting strategic directions, monitoring operational performance, and promoting continuous organizational development in order to support the Company’s sustainable growth, while taking into account the best interests of shareholders and all stakeholder
Audit Committee Duty Performance
Results of the Audit Committee's Duty Performance in the Past Year
The Audit Committee of Principal Capital Public Company Limited has performed its duties in accordance with the responsibilities assigned by the Board of Directors and as stipulated in the Audit Committee Charter, which are aligned with the regulations and best practice guidelines of the The Securities and Exchange Commission, Thailand (SEC) and the The Stock Exchange of Thailand (SET). The Audit Committee has adhered to principles of independence, transparency, and good corporate governance in order to build confidence among shareholders and all stakeholders.
During the year 2025, the Audit Committee convened a total of four meetings. All members attended every meeting, representing 100% attendance, which reflects their commitment to fully performing their duties. In addition, the Audit Committee held one meeting with the external auditor without the presence of management to discuss the auditor’s independence and matters identified from the audit.
The Audit Committee also held discussions to consider various business and internal control matters, exchanged views, received clarifications, made inquiries, and provided useful recommendations to management, the internal auditor, and the external auditor. The Committee emphasized enhancing corporate governance to address emerging risks, organizational sustainability, and governance practices. Details of its performance within the key areas of responsibility are as follows:
1) Review of the Company’s Financial Statements
The Audit Committee reviewed the consolidated and separate quarterly financial statements and the annual financial statements for the year 2025 together with management and the external auditor. The review focused on the accuracy, completeness, and reliability of financial information, as well as the adequacy of disclosures in the notes to the financial statements in accordance with Thai Accounting Standards (TAS) and Thai Financial Reporting Standards (TFRS) applicable to public interest entities. The external auditor issued an unqualified opinion prior to submission to the Board of Directors for approval and public disclosure. Particular attention was given to the following matters:
Internal Control: The Audit Committee reviewed with the external auditor the adequacy and appropriateness of the internal control system, covering operational, financial, and compliance aspects, to ensure that accounting information accurately reflected the Company’s operating results and complied with relevant financial reporting standards.
Significant Accounting Matters: The Audit Committee reviewed material transactions, accounting judgments, accounting estimates, revenue recognition from medical services, trade receivables (insurance counterparties and government schemes), allowance for doubtful accounts, and impairment testing of goodwill and other assets to ensure that the financial statements fairly reflected the business performance and that potential future risks were continuously monitored.
Liquidity and Debt Covenants: The Audit Committee oversaw the Company’s financial position, including identification of potential liquidity risks and risks of breaching debt covenants, and reviewed management’s plans for additional funding arrangements.
Operating Performance: The Audit Committee considered the Company’s operating performance, which was affected by both internal and external factors, such as economic conditions and international relations situations impacting hospitals in the northeastern region.
Based on the review and discussions with all relevant parties, the Audit Committee is of the opinion that the Company’s financial statements are accurate, complete, and reliable in all material respects and prepared in accordance with TAS and TFRS for public interest entities. The external auditor issued an unqualified opinion.
2) Review of Internal Control System and Internal Audit Function
The Audit Committee considered and approved the annual internal audit plan for 2025 and reviewed quarterly internal audit reports presented by the Head of Internal Audit. The Committee also continuously monitored the implementation of corrective actions based on audit recommendations, with emphasis on the following matters:
Internal Audit Enhancement and Development: The Audit Committee is committed to elevating the internal audit function to international standards by driving risk-based auditing to prioritize significant risks to the hospital business. The Committee also encouraged the adoption of Artificial Intelligence (AI) and data analytics tools to enhance audit efficiency and accuracy. Furthermore, the Head of Internal Audit was encouraged to attend key meetings, such as Board of Directors and Risk Management Committee meetings, to be informed of strategic directions, identify emerging risks, and anticipate control issues in advance.
Audit Finding Follow-up: The Audit Committee regularly monitored the progress of corrective actions, with particular focus on high-risk issues.
PDPA Compliance: The Audit Committee placed significant importance on compliance with the Personal Data Protection Act (PDPA), particularly challenges in collecting and retaining consent forms from patients for the collection, use, or disclosure of personal data. Recommendations were provided to management to enhance awareness and continuous training for employees.
IT General Controls: The Audit Committee reviewed IT general controls for key systems such as Centrix and PeopleSoft. In view of the plan to implement a new ERP system, the Committee proactively recommended coordination with the external auditor to align on IT audit approaches to ensure a smooth system transition and a robust control environment from the outset.
In addition, the Audit Committee approved the revised Internal Audit Charter to align with the latest Global Internal Audit Standards 2024. This action reflects the Company’s commitment to strengthening governance in line with international best practices and ensuring that the internal audit function operates in a modern and effective manner. Overall, the Audit Committee is of the opinion that the Company has an adequate and appropriate internal control system, that corrective actions based on internal and external audit recommendations are continuously followed up, and that the internal audit function operates independently and effectively.
3) Review of Connected Transactions, Acquisition and Disposal Transactions, and Potential Conflict of Interest Transactions
The Audit Committee reviewed connected transactions and transactions that may involve conflicts of interest to ensure appropriateness and compliance with relevant laws and regulations. In 2025, there were no transactions with other persons that may constitute conflicts of interest or connected transactions, except for normal business transactions between the Company and its subsidiaries. Such transactions were disclosed in the notes to the 2025 financial statements. The Audit Committee considered and concluded that these transactions were reasonable, conducted in the ordinary course of business, and on arm’s length terms and conditions.
4) Review of Compliance with Laws and Regulations
The Audit Committee reviewed compliance with the Securities and Exchange Act, regulations of the SEC and the SET, and other laws relevant to the Company’s business, as well as compliance with the Company’s internal regulations. The review was based on internal audit reports covering internal control and risk management assessments, as well as reports from the external auditor. The Committee emphasized to management the importance of keeping abreast of relevant laws and regulations to ensure that the Company conducts its business in full compliance.
5) Consideration of Risk Management
The Audit Committee acknowledged significant risks and monitored risk management activities, holding discussions and exchanging views with the Risk Management Committee to understand plans and approaches for managing key risks. The Audit Committee is of the opinion that the Company’s risk management system is appropriate for its current business operations. The Committee also recommended aligning risk management plans with the COSO ERM framework, emphasizing litigation risk, medical staff shortage risk, accounts receivable risk, and climate-related risk to ensure preparedness in line with future business strategies.
6) Consideration and Oversight of the External Auditor
The Audit Committee oversaw the performance and independence of the external auditor, PricewaterhouseCoopers ABAS Ltd., throughout 2025. Key actions included:
Independence: The Audit Committee assessed the independence of the external auditor and concluded that the auditor remained independent, with no issues that may give rise to conflicts of interest.
Approval of Fees: The Audit Committee considered and approved non-audit service fees, including inventory destruction observation services for Principal Healthcare – Sisaket Co., Ltd., and BOI application audits for Phitsanulok Ruam Phaet Co., Ltd. and Principal Healthcare – Chumphon Co., Ltd., determining that such services did not impair audit independence.
Coordination and Recommendations: The Committee discussed and provided direct recommendations to the external auditor, including suggesting a deeper understanding of business plans and different growth stages of each hospital to support goodwill impairment assessment analysis.
7) Consideration and Proposal for Appointment of External Auditor and Audit Fee for 2026
The Audit Committee considered the selection of the external auditor based on competence, expertise, professional knowledge, independence, past performance, and appropriateness of audit fees. The Board of Directors therefore resolved to propose to the shareholders’ meeting the appointment of auditors from PricewaterhouseCoopers ABAS Ltd. (PwC) as the Company’s external auditor for 2026 as follows:
1. Miss Yuwanan Manomivisit C.P.A. (Thailand) No. 9804 or
2. Miss Nopanuch Apichatsatien C.P.A. (Thailand) No. 5266 or
3. Mr. Krit Chatchavalwong C.P.A. (Thailand) No. 5016
Any one of the above auditors shall be authorized to audit and express an opinion on the Company’s financial statements. In the event that the above auditors are unable to perform their duties, PricewaterhouseCoopers ABAS Ltd. shall designate another certified public accountant from the firm to act in their place.
Overall Opinion of the Audit Committee
The Audit Committee of Principal Capital Public Company Limited has performed its duties throughout 2025 with due care, prudence, and independence. Based on its oversight and reviews within the scope of its responsibilities, the Audit Committee is of the opinion that the Company has prepared its financial reports accurately in all material respects, has an adequate and appropriate internal control system, and that the internal audit function operates independently and effectively. The Company has effective risk management, complies strictly with applicable laws and regulations relating to hospital operations, and conducts its business transparently in accordance with good corporate governance principles.
Mr. Kajornkiet Aroonpirodjanakul Chairman of the Audit Committee
Executive Committee Duty Performance
Results of the Executive Committee's Duty Performance in the Past Year
In 2025, the Executive Committee performed its duties as delegated by the Board of Directors, with a focus on driving sustainable growth in the healthcare services business, enhancing operational efficiency, and restructuring the organization to support future expansion. The Committee convened meetings at least once a month, and the key outcomes of its operations can be summarized under the following areas:
Business Expansion and Strategic Investments
• Expansion of the hospital network: Approved the investment for the construction of a new hospital in Kamphaeng Phet Province, and the acquisition of additional private hospitals, including projects in Kanchanaburi Province and Nakhon Ratchasima Province, in order to strengthen the Company’s competitive position in strategic locations.
• Development of specialized medical centers: Supported the establishment of Cancer and Radiotherapy Centers, the development of Centers of Excellence, and the expansion of investments in In Vitro Fertilization (IVF) technology through collaboration with specialized partners.
• Investment in related businesses: Approved an investment in a healthcare solutions company (Serviso) to further strengthen and extend the value chain of the Company’s core healthcare business.
Financial and Capital Structure Management
• Capital restructuring: Approved the reduction of the registered capital of a subsidiary (PRINH) to eliminate accumulated losses.
• Dividend policy: Considered and approved the principle of dividend payment to shareholders from retained earnings in order to enhance shareholder confidence and provide appropriate returns to stakeholders.
• Liquidity management: Monitored cash flow and arranged project financing from financial institutions to support ongoing hospital development projects within the network, while also considering alternative funding sources to serve as financial reserves for future business expansion.
Operational Excellence
• Organizational restructuring: Approved the establishment of HMS (Hospital Management Services) to centralize management functions and enhance service standards across hospitals within the network.
• Cost management: Emphasized policies to improve cost efficiency, particularly through effective workforce management, including the optimization of Full-Time Equivalent (FTE) Clinic staffing.
• Business portfolio optimization: Considered the discontinuation of unprofitable branches under the “Kai Bann Kai Jai Clinic (KBKJ)” community clinic model to reduce the negative impact on the Group’s overall financial performance.
Digital Innovation and Marketing Initiatives
• Monitored the development of the ERP system and the PRINC Doctor System (PDS), while initiating the use of Artificial Intelligence (AI) to improve operational efficiency and reduce costs.
• Explored modern marketing channels to expand revenue streams through E-Commerce platforms (HugSook website) and the implementation of a Customer Relationship Management (CRM) system (HubSpot) to support MarTech-based marketing strategies, including the application of AI in marketing activities.
Sustainability and Risk Management
• ESG initiatives: Monitored ESG-related activities across all three dimensions, including the identification of material sustainability issues, the implementation of human rights initiatives, and various environmental projects. The Committee also oversaw the preparation of Carbon Footprint assessments for hospitals within the network, the Company’s readiness for the FTSE Russell ESG Rating assessment, and the disclosure of sustainability-related information in accordance with IFRS S1 and IFRS S2 standards.
• Risk management: Monitored comprehensive risk management across strategic, financial, and clinical risks. This included overseeing the development of the PRINC Incident Report system for incident reporting, along with the establishment of preventive and corrective measures. The Committee also monitored the progress of hospitals within the network in obtaining internationally and nationally recognized accreditations such as JCI and HA, to enhance confidence among patients and service recipients.
The Executive Committee remains committed to performing its duties with transparency and prudence in order to deliver strong returns and improve the quality of life for the public through accessible and comprehensive healthcare services of high medical standards.
Mr. Wityavate Rukkulchon, (M.D.)
Chairman of the Executive Committee

